University of Michigan researchers are currently developing a pill that allows breast tumors to illuminate when exposed to infrared light.
A study based in Denmark showed that one-third of breast cancer patients have benign tumors that never become life threatening. Other women have very dense breast tissue that masks lumps, which results in death from cancers that are very treatable. Hence, mammograms are considered to be very unreliable.
The research team utilizes a dye that responds to infrared light, which can easily penetrate the body. Doctors can distinguish more easily a malignant cancer from a benign tumor with this method. The dye is adiministered orally, which is safer than intravenous dyes, which can cause severe reactions in some patients.